PMA device
Watchman Left Atrial Appendage (Laa) Closure Technology
Boston Scientific Corp · System, Appendage Closure, Left Atrial (NGV, Class III) · First FDA decision Mar 13, 2015, newest Mar 25, 2026Stroke prevention in atrial fibrillation
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
8
PMA pathway
Device trials
71
Naming "Watchman"
MAUDE reports
16,496
Brand "Watchman", since 2015
PubMed studies
1,257
Mentioning "Watchman"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Watchman Left Atrial Appendage (Laa) Closure Technology
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 8 decisions filed under this name.
- WATCHMAN LEFT ATRIAL APPENDAGE (LAA) CLOSURE TECHNOLOGYPMA supplement
P130013-S076 · Decided Mar 25, 2026 · 411 days after receipt · Normal 180 Day Track No User Fee
Device type: System, appendage closure, left atrial (NGV) · Cardiology
- WATCHMAN and WATCHMAN FLX Left Atrial Appendage Closure Devices with Delivery SystemsPMA supplement
P130013-S043 · Decided Sep 2, 2022 · 520 days after receipt · Normal 180 Day Track
Device type: System, appendage closure, left atrial (NGV) · Cardiology
P130013-S025 · Decided Mar 1, 2019 · 84 days after receipt · Normal 180 Day Track No User Fee
Device type: System, appendage closure, left atrial (NGV) · Cardiology
3 more FDA decisions with a free account
Older decisions: P130013-S001, P130013
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Percutaneous Left Atrial Appendage Closure (LAAC)National determinationOn the books20.34Updated Nov 4, 2026
- Percutaneous Left Atrial Appendage (LAA) Closure TherapyNational analysisReview closedCAG-00445NUpdated Sep 21, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Watchman", any status and sponsor, newest update first.
- Combined Pulsed-field Ablation (PFA) and Left Atrial Appendage Occlusion Using Watchman Flx or AmuletPivotal-lookingActive, not recruiting
Prince of Wales Hospital, Shatin, Hong KongAcademic, hospital or other
NCT05560204 · 200 participants (planned) · Start Jan 1, 2023 · Primary completion Dec 31, 2027
Device: Combined Pulsed-field Ablation (PFA) + Left Atrial Appendage Occlusion (LAAO) · For: Combined Pulsed-field Ablation (PFA)
Sites: Jordon, Hong Kong; Hong Kong, Hong Kong; Taipa, Macau
- CHAMPION-AF Clinical TrialPivotal-lookingActive, not recruiting
Boston Scientific CorporationPublic (BSX)
NCT04394546 · 3,000 participants · Start Oct 15, 2020 · Primary completion Dec 2027
Device: WATCHMAN FLX LAAC Device · For: Atrial Fibrillation; Stroke; Bleeding
Sites: Birmingham, Alabama; Phoenix, Arizona; Scottsdale, Arizona · 141 sites in all
- SIMPLAAFY Clinical TrialPivotal-lookingActive, not recruiting
Boston Scientific CorporationPublic (BSX)
NCT06521463 · 1,857 participants · Start Oct 1, 2024 · Primary completion Jul 7, 2026
Device: WATCHMAN FLX Pro LAAC Device · For: Atrial Fibrillation; Stroke; Bleeding
Sites: Birmingham, Alabama; Phoenix, Arizona; Scottsdale, Arizona · 86 sites in all
68 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Watchman", and for the whole product code for context.
This brand
16,496 reports: 1,882 malfunction, 13,002 injury, 1,605 death
Whole product code NGV
17,771 reports: 1,912 malfunction, 13,990 injury, 1,862 death
Newest reports for this brand
2124215-2026-57718 · Received Oct 30, 2026 · Event dated Oct 28, 2026
Device type: Catheter, Percutaneous (DQY)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Cardiac Arrest; Low Blood Pressure/ Hypotension; Low Cardiac Output; Thromboembolism; Thrombosis/Thrombus
- WATCHMAN FLX? ProInjury
2124215-2026-57534 · Received Oct 29, 2026 · Event dated Oct 21, 2026
Device type: System, Appendage Closure, Left Atrial (NGV)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Low Blood Pressure/ Hypotension; Pericardial Effusion
2124215-2026-57556 · Received Oct 29, 2026 · Event dated Sep 29, 2026
Device type: System, Appendage Closure, Left Atrial (NGV)
Device problem as coded: Difficult or Delayed Positioning
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2765-2015 · Started Aug 25, 2015
Reason given: Cross-threading of the hemostasis valve may occur if it is tightened with the dilator in place, possibly preventing subsequent sealing of the valve when desired. This Field Correction reinforces the Directions for Use (DFU) and gives further guidance on correct use of the hemostasis valve to avoid cross-threading and...
Cause as FDA categorized it: Use error · Device type: System, Appendage Closure, Left Atrial (NGV)
Z-2766-2015 · Started Aug 25, 2015
Reason given: Cross-threading of the hemostasis valve may occur if it is tightened with the dilator in place, possibly preventing subsequent sealing of the valve when desired. This Field Correction reinforces the Directions for Use (DFU) and gives further guidance on correct use of the hemostasis valve to avoid cross-threading and...
Cause as FDA categorized it: Use error · Device type: System, Appendage Closure, Left Atrial (NGV)
Published research
The most relevant PubMed records for "Watchman"[tiab]. The summary above synthesizes these.
- WATCHMAN.
Med Econ · 1950Biography
- Watchman FLX's Sophomore Year Report Card.
Dewland TA · J Am Heart Assoc · 2023Editorial, Comment
- The watchman.
Weinberg RB · Ann Intern Med · 2012
- Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial.
Lakkireddy D, Thaler D, Ellis CR, et al. · Circulation · 2021Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- Watching the watchman.
Block PC · J Am Coll Cardiol · 2007Comment, Editorial
- Watchman device migration and embolization: A report from the NCDR LAAO Registry.
Friedman DJ, Freeman JV, Zimmerman S, et al. · J Cardiovasc Electrophysiol · 2023Research Support, Non-U.S. Gov't
- Over Flexing of the WATCHMAN FLX Muscles in the Real World.
Alkhouli M · Circ Cardiovasc Interv · 2024Editorial, Comment
- Go Set a Watchman?
Bittl JA · JACC Cardiovasc Interv · 2015Editorial, Comment
- 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.
Reddy VY, Doshi SK, Kar S, et al. · J Am Coll Cardiol · 2017Multicenter Study, Randomized Controlled Trial
- WATCHMAN matches warfarin.
Expert Rev Cardiovasc Ther · 2009Comparative Study, News
- Half-Dose DOAC After Watchman Implantation.
Flores-Umanzor E, Cepas-Guillen P, Regueiro A, et al. · JACC Cardiovasc Interv · 2022Letter, Comment
- Early and late Watchman device migration and embolization: Insights from the NCDR LAAO registry.
Lin A · J Cardiovasc Electrophysiol · 2023Editorial, Comment
Other devices of this type
Also filed under product code NGV.
- WATCHMAN FLX Left Atrial Appendage (LAA) Closure TechnologyBoston Scientific Corp · PMA 2025
- WATCHMAN FLX Pro Left Atrial Appendage Closure Device with Delivery SystemBoston Scientific Corp · PMA 2025
- Amplatzer Amulet Left Atrial Appendage OccluderAbbott Medical · PMA 2025
- Amplatzer Amulet LAA OccluderAbbott Medical · PMA 2021
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.